• Profile
Close

Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement

Endocrine Connections Oct 14, 2017

Smith DJF, et al. - This study is performed to expand the evidence base for the utilization of hydrocortisone and prednisolone agents as replacement therapy. The outcome of this study suggests that the prednisolone once daily is more convenient than hydrocortisone thrice daily, and no difference is found in the markers of cardiovascular risk measured. Because prednisolone mimics the circadian rhythm better than other glucocorticoids, it ought to be considered as an option to hydrocortisone for adrenal insufficiency.

Methods

  • This study was conducted at Imperial College Healthcare Trust.
  • For this study, they analyzed data from 82 patients on hydrocortisone and 64 patients on prednisolone for adrenal insufficiency.

Results

  • No significant difference was seen in total cholesterol, LDL levels or any other risk factors between hydrocortisone and prednisolone patients.
  • In this study, they observed that the prednisolone was subjectively significantly more convenient than hydrocortisone (p=0.048).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay